基于人工智能多模态建模的乳腺X线虚拟活检
结果表明,AI结合临床与乳腺X线图像有助于识别乳腺病变亚型,可能辅助诊断流程并减少活检采样误差。
要点
- AI模型可基于乳腺X线和电子健康记录预测乳腺病变病理亚型。
- 以色列模型测试集AUC为0.88,美国模型为0.80,跨人群泛化性待验证。
- 该技术有望辅助评估诊断流程并减少活检采样误差。
核心结论
- AI应用于临床和乳腺X线图像可识别乳腺病变亚型,数据量足够大时结果提供支持证据。
研究设计与样本
- 训练数据包括有至少1年临床和影像病史、随后经活检病理诊断的个体,时间范围为2013年3月至2018年11月。
- 模型结合卷积神经网络与监督学习算法,分别在以色列2120名女性和美国1642名女性数据中独立训练。
- 以色列模型验证集456人、测试集441人(平均年龄51岁±11);美国模型验证集350人、测试集344人(平均年龄60岁±12)。
诊断标准与关键数值
- 预测恶性肿瘤的测试集包括220例以色列患者检查和126例美国患者检查(含导管原位癌或浸润性癌)。
- 以色列模型测试集AUC为0.88(95%CI: 0.85, 0.91),美国模型为0.80(95%CI: 0.74, 0.85)。
临床应用与阅片要点
- AI模型可结合乳腺X线和临床信息辅助预测病变病理亚型,有望用于评估诊断流程。
- 可能帮助减少活检采样误差,但需注意结果可能不适用于其他患者队列。
局限性
- 结果可能不适用于其他患者队列,跨人群泛化性需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Computational models based on artificial intelligence (AI) are increasingly used to diagnose malignant breast lesions. However, assessment from radiologic images of the specific pathologic lesion subtypes, as detailed in the results of biopsy procedures, remains a challenge. Purpose To develop an AI-based model to identify breast lesion subtypes with mammograms and linked electronic health records labeled with histopathologic information. Materials and Methods In this retrospective study, 26 569 images were collected in 9234 women who underwent digital mammography to pretrain the algorithms. The training data included individuals who had at least 1 year of clinical and imaging history followed by biopsy-based histopathologic diagnosis from March 2013 to November 2018. A model that combined convolutional neural networks with supervised learning algorithms was independently trained to make breast lesion predictions with data from 2120 women in Israel and 1642 women in the United States. Results were reported using the area under the receiver operating characteristic curve (AUC) with the 95% DeLong approach to estimate CIs. Significance was tested with bootstrapping. Results The Israeli model was validated in 456 women and tested in 441 women (mean age, 51 years ± 11 [SD]). The U.S. model was validated in 350 women and tested in 344 women (mean age, 60 years ± 12). For predicting malignancy in the test sets (consisting of 220 Israeli patient examinations and 126 U.S. patient examinations with ductal carcinoma in situ or invasive cancer), the algorithms obtained an AUC of 0.88 (95% CI: 0.85, 0.91) and 0.80 (95% CI: 0.74, 0.85) for Israeli and U.S. patients, respectively (P = .006). These results may not hold for other cohorts of patients, and generalizability across populations should be further investigated. Conclusion The results offer supporting evidence that artificial intelligence applied to clinical and mammographic images can identify breast lesion subtypes when the data are sufficiently large, which may help assess diagnostic workflow and reduce biopsy sampling errors. Published under a CC BY 4.0 license. Online supplemental material is available for this article.
引用
- Barros, Tlusty, Barkan, et al. Virtual Biopsy by Using Artificial Intelligence-based Multimodal Modeling of Binational Mammography Data. Radiology. 2022. PMID: 36283109. doi:10.1148/radiol.220027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。